Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRA [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing celecoxib suspension to naproxen suspension in juvenile arthritis has completed, evaluating efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis

Drugs mentioned

• Celecoxib (Celecoxib)
• Naproxen (Naproxen)

Snippet

Sponsor: Pfizer | Conditions: Arthritis, Juvenile Rheumatoid | Phase 3 | Status: COMPLETED